$ACNB

ELSNER FRANK III purchased $250 of ACNB

ELSNER FRANK III purchased 4 shares of ACNB CORP (ACNB) at $65.29 on 2026-09-15.

Original reporting
SEC EDGAR · ELSNER FRANK III
Published Sep 17, 2026, 1:53 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 1:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ACNB
Neutral
high confidence
Mentioned
$ACNB
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACNBNeutralLow
01

Why it matters

The purchase is too small to affect ACNB's stock price or broader market.

02

Market read

Limited relevance; primarily of interest to compliance monitoring.

03

What to watch

None

Relevance 4/10Novelty 4/10Timing: filing date 2026-09-17

Background

Form 4 filing discloses insider transactions to the SEC.

Company-level read

Ticker impact

$ACNBNeutralHigh confidence
Context

Director Elsner Frank III bought 4 shares at $65.29, increasing his stake to 29,071 shares.

Expected impact

No material price movement expected.

Evidence & confidence

The transaction size ($250) is trivial for a mid‑cap stock and unlikely to influence investor sentiment.

Market effects

none

none

none

Counterpoint

None

Key entities

  • Elsner Frank III

    Director of ACNB who purchased shares.

  • ACNB Corp

    Issuer of the shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACNBHigh

ACNB CORP (ACNB): We are pleased to report the strongest quarterly earnings performance in our Company's 169-year history, reflecting the enduring strength of our community…

ACNB CORP (ACNB) filed an SEC Form 8-K — Results of Operations and Financial Condition. PRESS RELEASE FOR IMMEDIATE RELEASE Contact: Jason H. Weber EVP/Treasurer & Chief Financial Officer 717.339.5090 jweber@acnb.com ACNB CORPORATION REPORTS RECORD 2026 THIRD QUARTER FINANCIAL RESULTS GETTYSBURG, PA, October 22, 2026 --- ACNB Corporation (NASDAQ: ACNB) (“ACNB” or th

$ACNBMed

ACNB CORP (ACNB): Results of Operations and Financial Condition

ACNB CORP (ACNB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 pressrelease2026-q2.htm EX-99.1 pressrelease2026-q2 PRESS RELEASE FOR IMMEDIATE RELEASE Contact: Jason H. Weber EVP/Treasurer & Chief Financial Officer 717.339.5090 jweber@acnb.com ACNB CORPORATION REPORTS RECORD 2026 SECOND QUARTER FINANCIAL RESULTS GETTYSBURG, PA, Jul

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).